XML 58 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Quarterly Data (Unaudited) (Tables)
 12 Months Ended
Apr. 30, 2021
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information
Selected quarterly financial data for fiscal years 2021 and 2020 were as follows:
$ in thousands, except per share amountsFirst
Quarter		Second
Quarter		Third
Quarter		Fourth
Quarter
Fiscal Year 2021
Net sales$36,423 $39,000 $33,339 $38,707 
Gross profit5,881 6,395 5,654 6,063 
Net (loss) earnings(608)(165)95 (2,929)
Less: net (loss) earnings attributable to the non-controlling interest(10)15 14 46 
Net (loss) earnings attributable to Kewaunee Scientific Corporation(598)(180)81 (2,975)
Net (loss) earnings per share attributable to Kewaunee Scientific Corporation
Basic(0.22)(0.07)0.03 (1.08)
Diluted(0.22)(0.07)0.03 (1.08)
Cash dividends paid per share— — — — 
Fiscal Year 2020
Net sales$39,336 $39,722 $34,225 $34,257 
Gross profit6,946 6,316 5,278 4,887 
Net earnings (loss)496 (2,161)(1,901)(1,058)
Less: net earnings attributable to the non-controlling interest25 17 17 4 
Net earnings (loss) attributable to Kewaunee Scientific Corporation471 (2,178)(1,918)(1,062)
Net earnings (loss) per share attributable to Kewaunee Scientific Corporation
Basic0.17 (0.79)(0.70)(0.39)
Diluted0.17 (0.79)(0.70)(0.39)
Cash dividends paid per share0.19 0.19 — —